Franklin Covey Exec Awarded Stock Grant as Part of Incentive Plan
FRANKLIN COVEY CO
Subscribe to track FC
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Franklin Covey Exec Awarded Stock Grant
Company: FRANKLIN COVEY CO (FC) Form: 4 | Filed: 2025/11/17 Significance: Low
Insider: Procter Holly Title: President, Enterprise Division | Relationship: Officer
Transaction: • Type: Grant • Shares: 7,298 • Price: $0.00 • Value: $0 • Owned After: 9,260
Key Insight: A routine stock grant to an executive as part of a long-term incentive plan. The grant represents a minor 0.058% potential dilution to shares outstanding.
Market Context: This is a non-market transaction with no immediate cash value, typical for executive compensation packages. The shares vest over three years starting in 2026.
This is PUBLIC SEC data for educational purposes. Not investment advice.
Comprehensive Analysis
SEC Filing Analysis: FRANKLIN COVEY CO (FC)
Executive Summary
- Trading Significance: Low
- Key Takeaway: An executive received a routine, pre-planned stock grant as part of a long-term incentive plan with a future vesting schedule.
- Market Impact: Neutral. This is a non-market compensation event with minimal immediate impact on the stock.
Company Information
| Field | Value |
|---|---|
| Company | FRANKLIN COVEY CO |
| Ticker Symbol | FC |
| CIK | 0000886206 |
| Industry | Services-Management Services |
Insider Information
| Field | Value |
|---|---|
| Name | Procter Holly |
| CIK | 0002083098 |
| Title/Position | President, Enterprise Division |
| Relationship | Officer |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 4 |
| Transaction Date | 2025-11-13 |
| Transaction Code | A (Grant) |
| Security Type | Common shares |
| Shares Involved | 7,298 |
| Price Per Share | $0.00 |
| Total Value | $0 |
| Shares Owned After | 9,260 |
| Ownership Type | Direct |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Transaction Value | $0 |
| % of Market Cap | 0.0% |
| Shares Transacted | 7,298 |
| % of Shares Outstanding | 0.058% |
| Post-Transaction Ownership | 9,260 shares (0.073% of outstanding) |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: Franklin Covey is a small-cap company with a market capitalization of approximately $180 million. This transaction has no monetary value.
- Ownership Concentration: The insider's post-transaction ownership of 9,260 shares is negligible, representing less than 0.1% of total shares outstanding.
- Dilution Impact: The grant of 7,298 shares represents a potential future dilution of 0.058%, which is minimal for existing shareholders.
- Transaction Significance: The transaction is a standard executive compensation grant with zero cost and represents a very small fraction of the company's outstanding shares, classifying its significance as Low.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: This is a non-market transaction (stock grant) with a $0 price, reflecting compensation rather than an investment decision by the insider. It does not signal new sentiment about the company's future prospects.
Volume & Sentiment
- Expected Volume Impact: None. The transaction did not occur on the open market.
- Sentiment Indicator: Neutral. Stock grants are a routine part of executive compensation and do not typically influence market sentiment.
Additional Context
Transaction Notes
- Special Circumstances: The filing footnote specifies this is a grant under the "FY26 LTIP" (Long-Term Incentive Plan) with a three-year vesting schedule beginning in November 2026. This confirms the grant is part of a structured compensation plan.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.
